Brokerages forecast that Davita Inc (NYSE:DVA) will post $3.89 billion in sales for the current quarter, Zacks reports. Six analysts have made estimates for Davita’s earnings, with the lowest sales estimate coming in at $3.83 billion and the highest estimate coming in at $3.99 billion. Davita posted sales of $3.72 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 4.6%. The firm is scheduled to announce its next quarterly earnings results on Thursday, February 15th.
According to Zacks, analysts expect that Davita will report full year sales of $3.89 billion for the current financial year, with estimates ranging from $15.31 billion to $15.49 billion. For the next fiscal year, analysts anticipate that the company will report sales of $12.05 billion per share, with estimates ranging from $11.07 billion to $13.65 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Davita.
Davita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, November 7th. The company reported $0.81 EPS for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.13). The business had revenue of $3.92 billion for the quarter, compared to the consensus estimate of $3.91 billion. Davita had a return on equity of 13.31% and a net margin of 3.40%. The firm’s revenue for the quarter was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.95 EPS.
A number of brokerages have commented on DVA. Robert W. Baird restated a “buy” rating and set a $95.00 price target (up previously from $82.00) on shares of Davita in a research note on Friday, January 12th. Bank of America restated a “buy” rating and set a $92.00 price target (up previously from $85.00) on shares of Davita in a research note on Thursday, January 11th. TheStreet upgraded shares of Davita from a “c” rating to a “b-” rating in a research note on Thursday, January 4th. Zacks Investment Research upgraded shares of Davita from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. Finally, SunTrust Banks set a $75.00 price target on shares of Davita and gave the stock a “hold” rating in a research note on Thursday, December 21st. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, four have issued a buy rating and two have issued a strong buy rating to the company’s stock. Davita presently has an average rating of “Hold” and a consensus price target of $78.22.
In other news, insider James K. Hilger sold 3,572 shares of Davita stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total value of $282,009.40. Following the completion of the transaction, the insider now owns 33,649 shares in the company, valued at $2,656,588.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Leanne M. Zumwalt sold 949 shares of Davita stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $68.19, for a total transaction of $64,712.31. Following the completion of the transaction, the vice president now owns 12,423 shares of the company’s stock, valued at approximately $847,124.37. The disclosure for this sale can be found here. Insiders sold 121,509 shares of company stock valued at $8,310,388 in the last quarter. 2.10% of the stock is currently owned by corporate insiders.
Several large investors have recently bought and sold shares of the company. Schwab Charles Investment Management Inc. raised its stake in shares of Davita by 2.4% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 587,575 shares of the company’s stock valued at $42,453,000 after acquiring an additional 14,040 shares during the last quarter. California Public Employees Retirement System raised its stake in shares of Davita by 1.9% in the third quarter. California Public Employees Retirement System now owns 490,132 shares of the company’s stock valued at $29,109,000 after acquiring an additional 9,332 shares during the last quarter. Canada Pension Plan Investment Board raised its stake in shares of Davita by 14.7% in the third quarter. Canada Pension Plan Investment Board now owns 444,358 shares of the company’s stock valued at $26,390,000 after acquiring an additional 56,988 shares during the last quarter. Schroder Investment Management Group raised its stake in shares of Davita by 769.0% in the third quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock valued at $25,387,000 after acquiring an additional 384,224 shares during the last quarter. Finally, Hikari Power Ltd raised its stake in shares of Davita by 6.9% in the fourth quarter. Hikari Power Ltd now owns 333,920 shares of the company’s stock valued at $24,126,000 after acquiring an additional 21,620 shares during the last quarter. Institutional investors own 87.97% of the company’s stock.
Davita (NYSE:DVA) opened at $78.61 on Friday. The company has a market cap of $14,410.00, a PE ratio of 30.12 and a beta of 0.96. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.35 and a current ratio of 1.40. Davita has a one year low of $52.51 and a one year high of $80.71.
Davita declared that its board has initiated a share repurchase plan on Tuesday, October 10th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s management believes its stock is undervalued.
ILLEGAL ACTIVITY WARNING: “Analysts Expect Davita Inc (DVA) Will Post Quarterly Sales of $3.89 Billion” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://ledgergazette.com/2018/02/12/analysts-expect-davita-inc-dva-will-post-quarterly-sales-of-3-89-billion.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.